154 related articles for article (PubMed ID: 15531734)
1. Adrenomedullin is highly expressed in blood monocytes associated with acute Kawasaki disease: a microarray gene expression study.
Nomura I; Abe J; Noma S; Saito H; Gao B; Wheeler G; Leung DY
Pediatr Res; 2005 Jan; 57(1):49-55. PubMed ID: 15531734
[TBL] [Abstract][Full Text] [Related]
2. Tissue inhibitor of metalloproteinase 2 and coronary artery lesions in Kawasaki disease.
Furuno K; Takada H; Yamamoto K; Ikeda K; Ohno T; Khajoee V; Mizuno Y; Hara T
J Pediatr; 2007 Aug; 151(2):155-60, 160.e1. PubMed ID: 17643768
[TBL] [Abstract][Full Text] [Related]
3. Aberrantly decreased levels of NKG2D expression in children with kawasaki disease.
Ge X; Li CR; Yang J; Wang GB
Scand J Immunol; 2013 May; 77(5):389-97. PubMed ID: 23298273
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis of peripheral blood mononuclear cells in Kawasaki disease.
Kim HY; Lee HG; Kim DS
J Rheumatol; 2000 Mar; 27(3):801-6. PubMed ID: 10743828
[TBL] [Abstract][Full Text] [Related]
5. [Expressions of plasma SDF-1 and its receptor CXCR4 in peripheral blood mononuclear cells of children with Kawasaki disease].
Zhang J; Gui YH; Yang Y
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Aug; 8(4):283-6. PubMed ID: 16923357
[TBL] [Abstract][Full Text] [Related]
6. Expression of myeloid-related protein-8 and -14 in patients with acute Kawasaki disease.
Hirono K; Foell D; Xing Y; Miyagawa-Tomita S; Ye F; Ahlmann M; Vogl T; Futatani T; Rui C; Yu X; Watanabe K; Wanatabe S; Tsubata S; Uese K; Hashimoto I; Ichida F; Nakazawa M; Roth J; Miyawaki T
J Am Coll Cardiol; 2006 Sep; 48(6):1257-64. PubMed ID: 16979015
[TBL] [Abstract][Full Text] [Related]
7. Neutrophils and mononuclear cells express vascular endothelial growth factor in acute Kawasaki disease: its possible role in progression of coronary artery lesions.
Hamamichi Y; Ichida F; Yu X; Hirono KI; Uese KI; Hashimoto I; Tsubata S; Yoshida T; Futatani T; Kanegane H; Miyawaki T
Pediatr Res; 2001 Jan; 49(1):74-80. PubMed ID: 11134495
[TBL] [Abstract][Full Text] [Related]
8. [Matrix metalloproteinase-1 expression in the circulation of patients with Kawasaki disease and its role in the pathogenesis of coronary artery lesions].
Yang SW; Wang DW; Li J; Qin YM; Wang FM; Cao LM; Zhang LF; Hu Z
Zhonghua Er Ke Za Zhi; 2005 Aug; 43(8):612-5. PubMed ID: 16191276
[TBL] [Abstract][Full Text] [Related]
9. [Changes and significance for regulatory factors for signal pathways of Toll-like receptors in immunological pathogenesis of Kawasaki disease].
Wang GB; Li CR; Zu Y; Yang WG
Zhonghua Er Ke Za Zhi; 2008 Jan; 46(1):49-54. PubMed ID: 18353240
[TBL] [Abstract][Full Text] [Related]
10. [Expression of monocyte chemotactic protein-1 in peripheral blood mononuclear cells of children with Kawasaki disease and its relation to coronary artery impairment].
Zhang J; Gui YH; Yang Y
Zhonghua Er Ke Za Zhi; 2008 Feb; 46(2):132-5. PubMed ID: 19099689
[TBL] [Abstract][Full Text] [Related]
11. Enhanced iNOS expression in leukocytes and circulating endothelial cells is associated with the progression of coronary artery lesions in acute Kawasaki disease.
Yu X; Hirono KI; Ichida F; Uese K; Rui C; Watanabe S; Watanabe K; Hashimoto I; Kumada T; Okada E; Terai M; Suzuki A; Miyawaki T
Pediatr Res; 2004 Apr; 55(4):688-94. PubMed ID: 14764920
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling of the effect of high-dose intravenous Ig in patients with Kawasaki disease.
Abe J; Jibiki T; Noma S; Nakajima T; Saito H; Terai M
J Immunol; 2005 May; 174(9):5837-45. PubMed ID: 15843588
[TBL] [Abstract][Full Text] [Related]
13. Unique activation status of peripheral blood mononuclear cells at acute phase of Kawasaki disease.
Ikeda K; Yamaguchi K; Tanaka T; Mizuno Y; Hijikata A; Ohara O; Takada H; Kusuhara K; Hara T
Clin Exp Immunol; 2010 May; 160(2):246-55. PubMed ID: 20015095
[TBL] [Abstract][Full Text] [Related]
14. High mobility group box 1 (HMGB1) and macrophage migration inhibitory factor (MIF) in Kawasaki disease.
Hoshina T; Kusuhara K; Ikeda K; Mizuno Y; Saito M; Hara T
Scand J Rheumatol; 2008; 37(6):445-9. PubMed ID: 18720262
[TBL] [Abstract][Full Text] [Related]
15. Evidence for RANTES, monocyte chemotactic protein-1, and macrophage inflammatory protein-1 beta expression in Kawasaki disease.
Wong M; Silverman ED; Fish EN
J Rheumatol; 1997 Jun; 24(6):1179-85. PubMed ID: 9195529
[TBL] [Abstract][Full Text] [Related]
16. Decreased nitric oxide production after intravenous immunoglobulin treatment in patients with Kawasaki disease.
Wang CL; Wu YT; Lee CJ; Liu HC; Huang LT; Yang KD
J Pediatr; 2002 Oct; 141(4):560-5. PubMed ID: 12378198
[TBL] [Abstract][Full Text] [Related]
17. Increased serum levels of vascular endothelial growth factor in Kawasaki disease.
Maeno N; Takei S; Masuda K; Akaike H; Matsuo K; Kitajima I; Maruyama I; Miyata K
Pediatr Res; 1998 Oct; 44(4):596-9. PubMed ID: 9773852
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of human 63-kD heat shock protein gene in Kawasaki disease determined by quantitative reverse transcription-polymerase chain reaction.
Takeshita S; Kawase H; Yamamoto M; Fujisawa T; Sekine I; Yoshioka S
Pediatr Res; 1994 Feb; 35(2):179-83. PubMed ID: 8165052
[TBL] [Abstract][Full Text] [Related]
19. [The role of activation of toll-like receptors in immunological pathogenesis of Kawasaki disease].
Wang GB; Li CR; Zu Y; Yuan XW
Zhonghua Er Ke Za Zhi; 2006 May; 44(5):333-6. PubMed ID: 16780707
[TBL] [Abstract][Full Text] [Related]
20. Adrenomedullin in monocytes and macrophages: possible involvement of macrophage-derived adrenomedullin in atherogenesis.
Nakayama M; Takahashi K; Murakami O; Murakami H; Sasano H; Shirato K; Shibahara S
Clin Sci (Lond); 1999 Aug; 97(2):247-51. PubMed ID: 10409481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
